These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 20118678)
1. Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase. Steib CJ; Bilzer M; Härtl JM; Beitinger F; Gülberg V; Göke B; Gerbes AL Shock; 2010 Apr; 33(4):412-8. PubMed ID: 20118678 [TBL] [Abstract][Full Text] [Related]
2. Amiloride reduces portal hypertension in rat liver cirrhosis. Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467 [TBL] [Abstract][Full Text] [Related]
3. Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis. Steib CJ; Bilzer M; op den Winkel M; Pfeiler S; Hartmann AC; Hennenberg M; Göke B; Gerbes AL Hepatology; 2010 Jun; 51(6):2086-96. PubMed ID: 20512996 [TBL] [Abstract][Full Text] [Related]
4. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). Steib CJ; Gerbes AL; Bystron M; Op den Winkel M; Härtl J; Roggel F; Prüfer T; Göke B; Bilzer M J Hepatol; 2007 Aug; 47(2):228-38. PubMed ID: 17573142 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. Thakali K; Davenport L; Fink GD; Watts SW J Pharmacol Exp Ther; 2007 Jan; 320(1):236-43. PubMed ID: 17003231 [TBL] [Abstract][Full Text] [Related]
6. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects. Klein S; Van Beuge MM; Granzow M; Beljaars L; Schierwagen R; Kilic S; Heidari I; Huss S; Sauerbruch T; Poelstra K; Trebicka J J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469 [TBL] [Abstract][Full Text] [Related]
7. The effects of hepatic steatosis on thromboxane A Zhang J; Schewe J; Li H; Makeschin MC; Mahajan UM; Gerbes AL; Steib CJ Gastroenterol Hepatol; 2019 Nov; 42(9):534-541. PubMed ID: 31326104 [TBL] [Abstract][Full Text] [Related]
8. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715 [TBL] [Abstract][Full Text] [Related]
9. LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver. Miller AM; Masrorpour M; Klaus C; Zhang JX J Hepatol; 2007 Feb; 46(2):276-85. PubMed ID: 17161492 [TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats. Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606 [TBL] [Abstract][Full Text] [Related]
11. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. Yang YY; Huang YT; Tsai TH; Hou MC; Lee FY; Lee SD; Lin HC Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967 [TBL] [Abstract][Full Text] [Related]
13. Activation of rho is involved in the mechanism of hydrogen-peroxide-induced lung edema in isolated perfused rabbit lung. Chiba Y; Ishii Y; Kitamura S; Sugiyama Y Microvasc Res; 2001 Sep; 62(2):164-71. PubMed ID: 11516245 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373 [TBL] [Abstract][Full Text] [Related]
15. Role of thromboxane A2 in early BDL-induced portal hypertension. Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905 [TBL] [Abstract][Full Text] [Related]
16. Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Nieto N Hepatology; 2006 Dec; 44(6):1487-501. PubMed ID: 17133487 [TBL] [Abstract][Full Text] [Related]
17. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents. Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286 [TBL] [Abstract][Full Text] [Related]
19. Protective effects against hydrogen peroxide-induced toxicity by activators of the ATP-sensitive potassium channel in isolated rat hearts. Gan XT; Cook MA; Moffat MP; Karmazyn M J Mol Cell Cardiol; 1998 Jan; 30(1):33-41. PubMed ID: 9500862 [TBL] [Abstract][Full Text] [Related]
20. Lymphocyte adherence in the reperfused rat liver: mechanisms and effects. Clavien PA; Harvey PR; Sanabria JR; Cywes R; Levy GA; Strasberg SM Hepatology; 1993 Jan; 17(1):131-42. PubMed ID: 8380789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]